Healthcare - Press Releases

Exciting expansion into Africa

HONG KONG, Feb. 24, 2025 /PRNewswire/ --Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that its partner on ivonescimab, Summit Therapeutics Inc. (NASDAQ: SMMT) has entered into a clinical trial collaboration with Pfizer Inc. (NYSE: PFE) to evaluate ivonescimab, a novel, investigational PD-1 / VEGF bispecific antibody, in combination with several of Pfizer's antibody drug conjugates (ADCs) across multiple solid tumor settings.

JSG will serve as a Sports Marketing Agency of Record for the rapidly growing regional QSR brand

SUZHOU, China, Feb. 24, 2025 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of anti-cancer therapies, today announced the publication of the GEMSTONE-303 study results for sugemalimab(brand name: Cejemly) in the prestigiousJournal of the American Medical Association (JAMA) .

RALEIGH, N.C., Feb. 24, 2025 /PRNewswire/ -- Kineticos Life Sciences announces the launch of Kinvard Bio, Inc., a newly established anti-infectives biotech company based on groundbreaking research that has been exclusively licensed from the Myers Lab in the Department of Chemistry and Chemical Biology at Harvard University and funded by the Kineticos AMR Accelerator Fund I (KAMRA I).

Rapid Initiation Protocol Reduces Time to Treatment with SUBLOCADE From One Week to One Hour, A Significant Advancement in the Treatment of Moderate to Severe Opioid Use Disorder (OUD)

VIENNE et SOUL, Core du Sud, 24 fvrier 2025 /PRNewswire/ -- Coreline Soft, spcialiste de l'IA mdicale, participera au Congrs europen de radiologie (ECR) 2025, qui se tiendra l'Austria Center Vienna du 26 fvrier au 2 mars. L'ECR est la plus grande confrence de radiologie d'Europe, laquelle participent des radiologues et des entreprises de dispositifs mdicaux du monde entier. Coreline Soft prsentera la gamme entirement renouvele AVIEW, y compris son produit principal, AVIEW (LCS Plus), au stand 107.

VIENNA and SEOUL, South Korea, Feb. 24, 2025 /PRNewswire/ -- Coreline Soft, a medical AI specialist, will participate in the European Congress of Radiology (ECR) 2025, held at the Austria Center Vienna from February 26 to March 2. ECR is Europe's largest radiology conference, attended by radiologists and medical device companies worldwide. Coreline Soft will unveil the completely renewed All New AVIEW lineup, including its main product, AVIEW (LCS Plus), at booth #107.

LINKPING, Sweden, Feb. 24, 2025 /PRNewswire/ -- International medical imaging IT and cybersecurity companySectra(STO: SECT B) and Siemens Healthineers AG are collaborating to improve radiologists' diagnostic capabilities and, as such, patient care through a seamless integration. The two companies are working together to enable radiologists to access and post-process Siemens Healthineers' NAEOTOM Alpha class photon-counting CT (PCCT) images within Sectra's diagnostic application for radiology. This integration avoids the need for Sectra users to switch to a separate application or workstation for efficient PCCT viewing.

SOPHiA GENETICS enables institutions across the globe to launch world-class oncology testing

La Agencia Europea de Medicamentos (EMA) ha aprobado una opcin adicional de administracin subcutnea de TAKHZYRO (lanadelumab) para pacientes de 12 aos o ms con ataques recurrentes de angioedema hereditario (AEH)

- Coreline Soft presenta el nuevo AVIEW en ECR 2025: el cribado del cncer de pulmn redefinido por la inteligencia artificial

WIEN und SEOUL, Sdkorea, 24. Februar 2025 /PRNewswire/ -- Coreline Soft, ein Spezialist fr medizinische KI, wird an dem European Congress of Radiology (ECR) 2025 teilnehmen, der vom 26. Februar bis 2. Mrz im Austria Center Vienna stattfindet. Der ECR ist Europas grte Radiologiekonferenz, an der Radiologen und Medizintechnikunternehmen aus aller Welt teilnehmen. Coreline Soft wird die vollstndig erneuerte AVIEW-Produktreihe an Stand 107 vorstellen, einschlielich des Hauptprodukts AVIEW (LCS Plus).

Impacting Affordable Housing Management and Housing Development

RIVERVIEW, Fla., Feb. 21, 2025 /PRNewswire/ -- Next month, the Florida Society of Clinical Oncology (FLASCO) is holding the annual 2025 FLASCO Fellows & Residents Training Program, a one-day educational event designed to empower and support the next generation of oncology professionals. The program will take place on March 22, 2025, at the JW Marriott Bonnet Creek Resort & Spa in Orlando, FL.

WINSTON-SALEM, N.C., Feb. 21, 2025 /PRNewswire/ --At Piedmont Advantage Credit Union's annual PACU Day event, held each year on President's Day, credit union employees gather for a day dedicated to professional growth and hearing directly from leadership on the state of the credit union.

The Company is withdrawing current submission based on FDA feedback related to shelf-life stability of a test component

ALAMEDA, Calif., Feb. 21, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, announced today that after 17 years of distinguished service, Don Kassinghas notified the company that he will retire from the board of directors effective April 1, 2025. Kassing joined Penumbra's Board of Directors in 2008 and has served as Presiding Director since 2015.

SAN DIEGO, Feb. 21, 2025 /PRNewswire/ --Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs), today announced that onFebruary 20, 2025,the Human Capital Management Committee of Avidity's Board of Directors granted non-qualified stock option awards to purchase an aggregate of 107,000 shares of its common stock and 53,500 restricted stock units ("RSUs") to twenty-two (22) new non-executive employees under the Avidity Biosciences, Inc. 2022 Employment Inducement Incentive Award Plan (the "2022 Inducement Plan"). The awards were granted as inducements material to the employees entering into employment with Avidity in accordance with Nasdaq Listing Rule 5635(c)(4).

KING OF PRUSSIA, Pa., Feb. 21, 2025 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that Steve Filton, Executive Vice President, and Chief Financial Officer will present at the following conferences:

LAKELAND, Fla., Feb. 21, 2025 /PRNewswire/ -- Florida Southern College is thrilled to announce a new articulation agreement for Pre-Medical students with the Orlando College of Osteopathic Medicine (OCOM).

MARLBOROUGH, Mass., Feb. 21, 2025 /PRNewswire/ -- Boston Scientific Corporation (the "Company") (NYSE:BSX) today announced that American Medical Systems Europe B.V. ("AMS Europe"), its wholly owned finance subsidiary, has priced a public offering of EUR850,000,000 aggregate principal amount of 3.000% notes due 2031 and EUR650,000,000 aggregate principal amount of 3.250% notes due 2034 (collectively, the "Notes"). The Notes will be fully and unconditionally guaranteed by the Company. The offering is being made pursuant to a registration statement filed with the U.S. Securities and Exchange Commission.

Food Safety Advocate Questions Why Foodborne Illness Outbreaks are Unreported by thePremier Public Health Agency in the Time of Trump

THON Reaches Remarkable Financial Milestone After 46-Hour No-Sitting, No-Sleeping Dance Marathon Raises $17.7 Million for Families Affected by Childhood Cancer

HONG KONG, Feb. 23, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, announced today that the Company has been selected and will be included as a constituent of the Hang Seng Composite Index by Hang Seng Indexes Company Limited, with effect from March 10, 2025.